In this Q&A published in the July/August 2022 issue of EuroTimes, Elliot Friedman, CEO of Elios Vision, Inc., and Murray Johnstone, MD, a clinical professor at the University of Washington and member of the ELIOS medical advisory board, discuss how the ELIOS excimer laser trabeculostomy procedure could change the future of glaucoma treatment.
A vision for a new era in combined glaucoma and cataract treatment
Share This Story
Latest News
Join Us for a Symposium During EGS in Dublin
Elios Vision will be hosting a symposium, “Excimer lasers in glaucoma: More than meets the eye,” during the EGS congress in Dublin.
Video: Combined Phacoemulsification and ELIOS for Medication Reduction
Dr. Antonio Moreno-Valladares discusses a recent study of medication reduction outcomes for the ELIOS procedure combined with phacoemulsification.
Elios Vision announces collaboration with the International Glaucoma Surgical Registry
Elios Vision will be collaborating with the ISGR, an open-access tool which enables surgeons to compare outcomes with other centres.